Clinical Trials
2 trialsNCT07277452 2025-12-11
NOTABLE-309
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
NCT06938503 2025-04-22
AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting